Fertility knowledge · 21 recommendations
PPOS: the 2026 expert consensus
Explore the clinical questions behind progestin-primed ovarian stimulation, one recommendation at a time.
PPOS generally involves a freeze-all strategy rather than fresh embryo transfer. The recommendation grades below are retained from the source.
DanRuo ·
Explore by topic
When should progestin start?
Start progestin when the estrogen level is below 70 pg/mL (2C).
Source: 2026 PPOS · Recommendation 1
Start progestin with ovarian stimulation
In PPOS, progestin should begin at the start of ovarian stimulation (1B). This differs from a GnRH antagonist protocol, in which the antagonist may be added several days after stimulation begins, once estrogen levels have risen.
Source: 2026 PPOS · Recommendation 2
Before luteal-phase stimulation
Patients preparing for luteal-phase ovarian stimulation should use contraception before ovulation to reduce the risk of severe OHSS associated with unintended pregnancy (1B).
Source: 2026 PPOS · Recommendation 3
Avoid retrieval during menstruation
Progestin supplementation in the late luteal phase is suggested to avoid performing oocyte retrieval during menstruation (2C).
Source: 2026 PPOS · Recommendation 4
Support the ovarian response
Combining luteal-phase stimulation with letrozole or clomiphene is recommended to enhance ovarian responsiveness (1C).
Source: 2026 PPOS · Recommendation 5
Which trigger for luteal-phase stimulation?
A GnRH agonist-only trigger is preferred for luteal-phase stimulation, particularly in patients at high risk of OHSS with a normal pituitary response (1A).
Source: 2026 PPOS · Recommendation 6
When might a dual trigger be considered?
For patients at risk of a low response to a GnRH agonist trigger, or with a history of low oocyte retrieval or maturation rates, 1,000–5,000 IU hCG may be added as a dual trigger (1B).
Source: 2026 PPOS · Recommendation 7
Adjuncts in follicular-phase PPOS
In follicular-phase PPOS, combining letrozole or clomiphene does not impair progestin’s blockade of estrogen-positive feedback and may reduce gonadotropin use and clinic visits (1B).
Source: 2026 PPOS · Recommendation 8
Choosing a progestin
The preferred options are medroxyprogesterone acetate (MPA), 4–10 mg/day, or dydrogesterone, 20–30 mg/day, with comparable efficacy and safety (1A).
Source: 2026 PPOS · Recommendation 9
When can a second stimulation begin?
The suggested starting criterion for double stimulation is at least 3 antral follicles measuring less than 8 mm across both ovaries after oocyte retrieval (1B).
Source: 2026 PPOS · Recommendation 10
Who may benefit from double stimulation?
Double stimulation is suitable for patients with diminished ovarian reserve, those requiring urgent fertility preservation, those with few oocytes retrieved in the follicular phase, or those repeatedly obtaining no usable embryos with conventional protocols (1C).
Source: 2026 PPOS · Recommendation 11
When is double stimulation not recommended?
Double stimulation is not recommended for patients with normal ovarian reserve who have a poor ovarian response to their first stimulation (2C).
Source: 2026 PPOS · Recommendation 12
Which first trigger for double stimulation?
In the follicular-phase component of double stimulation, a GnRH agonist trigger is recommended rather than a conventional-dose hCG trigger (1B). Patients who used a GnRH agonist downregulation protocol in the follicular phase and require an hCG trigger are not suitable for double stimulation (2C).
Source: 2026 PPOS · Recommendation 13
PPOS for high responders
For patients with a high ovarian response, PPOS with a GnRH agonist trigger is recommended (1B).
Source: 2026 PPOS · Recommendation 14
PPOS for normal responders
For patients with a normal ovarian response, PPOS is an important option within a freeze-all strategy (1B).
Source: 2026 PPOS · Recommendation 15
PPOS for low responders
For patients with a low ovarian response, PPOS, including luteal-phase stimulation or double stimulation, is recommended. It can provide stable control of the LH surge and support oocyte developmental potential (1B).
Source: 2026 PPOS · Recommendation 16
PPOS and endometriosis
Patients with endometriosis may use PPOS (2B).
Source: 2026 PPOS · Recommendation 17
PPOS and obesity
For patients with uncomplicated obesity (BMI ≥28 kg/m²), PPOS combined with frozen embryo transfer is recommended and may improve pregnancy outcomes (1C).
Source: 2026 PPOS · Recommendation 18
PPOS for PGT treatment
For patients undergoing preimplantation genetic testing (PGT), PPOS offers greater convenience and more favorable health-economic value (1C).
Source: 2026 PPOS · Recommendation 19
Fertility preservation before cancer treatment
PPOS or double stimulation is recommended for fertility preservation in patients with cancer (1B).
Source: 2026 PPOS · Recommendation 20
What does the evidence say about safety?
Current evidence indicates that PPOS does not increase the risk of birth defects or adverse neonatal outcomes (1B).
Source: 2026 PPOS · Recommendation 21
Current neonatal findings do not establish long-term offspring safety; longer follow-up is needed.
Consensus experts
Source
Reproductive Health Professional Committee of the Chinese Rehabilitation Medicine Association. Expert consensus on the clinical application of the progestin-primed ovarian stimulation protocol (2026). Chinese Journal of Reproduction and Contraception. 2026;46(10):1001–1009.
DOI: 10.3760/cma.j.cn101441-20260423-00179An educational translation of the 2026 Chinese expert consensus, not an official English edition. Medication and treatment decisions require individual clinical assessment.
Fertility Group